If you’ve been on a sleep medication for more than a few months and started asking whether it’s actually safe to keep taking, you’re not alone. The doxepin vs trazodone question comes up constantly, partly because both drugs get prescribed off-label for insomnia, and partly because neither one is a controlled substance like zolpidem or temazepam.<\/p>\n
That feels reassuring on the surface. Non-controlled, older, well-studied. But "old and familiar" isn’t the same thing as "safe forever," and the long-term picture for these two drugs is genuinely different.<\/p>\n
Here’s what a pharmacist would walk you through at the counter if you had fifteen minutes and a real question about which one to stay on.<\/p>\n
Both are technically antidepressants. Both are used at much lower doses for sleep than for depression. That’s where the similarity ends.<\/p>\n
Doxepin is a tricyclic antidepressant. At sleep doses (typically 3 to 6 mg), it works almost entirely as a histamine H1 blocker, which is what makes you drowsy. The low-dose formulation is FDA-approved specifically for sleep maintenance insomnia<\/a>, meaning trouble staying asleep rather than falling asleep.<\/p>\n Trazodone is a serotonin modulator. It’s FDA-approved for depression at doses of 150 to 600 mg per day, but the vast majority of trazodone prescriptions written in the US are for sleep, off-label, at 25 to 100 mg. The American Academy of Sleep Medicine’s 2017 clinical practice guideline<\/a> actually recommends against<\/em> using trazodone for chronic insomnia in most adults because the evidence base is thin compared to drugs studied at sleep-specific doses.<\/p>\n That’s the first big asymmetry in the doxepin vs trazodone comparison. One is approved for sleep. The other is borrowed from the depression toolbox.<\/p>\n Short-term, both drugs feel similar to a lot of patients: drowsy, slightly groggy in the morning, dry mouth, maybe a bit of next-day fog. The longer-term picture is where they diverge.<\/p>\n Doxepin at low doses (3 to 6 mg):<\/strong><\/p>\n Doxepin at higher doses (anything above 25 mg):<\/strong><\/p>\n Trazodone for sleep (typically 25 to 100 mg):<\/strong><\/p>\n The fall-risk piece is the one that quietly causes the most harm. Trazodone-associated falls in older adults are well-documented in nursing-home data, and a hip fracture at 78 changes the trajectory of someone’s life more than the insomnia ever did.<\/p>\n For most healthy adults under 65, the doxepin vs trazodone comparison tilts toward low-dose doxepin if the goal is sleep maintenance and the dose stays at or below 6 mg. The evidence base is cleaner. The side effect load is lower. There’s no controlled-substance status and no meaningful tolerance issue in trials.<\/p>\n Trazodone has a place. If someone has comorbid depression, anxiety, or PTSD-related sleep disruption, trazodone at 50 to 100 mg can do double duty in a way doxepin really can’t. Patients with restless legs sometimes do better on trazodone too.<\/p>\n But "double duty" cuts both ways. If you’re taking trazodone purely for sleep, you’re accepting the serotonergic side effect profile, the orthostatic hypotension risk, and the small but non-zero priapism risk for a benefit that low-dose doxepin probably delivers more cleanly.<\/p>\n For a broader look at how trazodone stacks up against another common sleep antidepressant, our piece on trazodone vs mirtazapine for sleep<\/a> walks through that head-to-head in detail.<\/p>\n Older adults.<\/strong> Both drugs carry Beers Criteria warnings, but low-dose doxepin (3 mg and 6 mg specifically) is the exception explicitly carved out. Above 6 mg, doxepin becomes problematic. Trazodone at any dose carries the fall-risk flag.<\/p>\n Patients on other serotonergic drugs.<\/strong> SSRIs, SNRIs, tramadol, triptans. Trazodone adds to serotonergic load and the rare risk of serotonin syndrome. Doxepin is cleaner here.<\/p>\n Patients with cardiac disease.<\/strong> Both can prolong QT, but trazodone at sleep doses is generally lower risk than doxepin at antidepressant doses. At low sleep doses of doxepin, cardiac risk is minimal.<\/p>\n Patients with dementia or mild cognitive impairment.<\/strong> Anticholinergic exposure is linked to worse cognition over time. If you’re already thinking about cognitive risk, our discussion of warning signs to watch for with dementia medications like donepezil<\/a> is worth a look. The same anticholinergic concern shows up across drug classes.<\/p>\n If you’re weighing controlled vs non-controlled sleep options more broadly, the comparison of suvorexant vs zolpidem for long-term insomnia safety<\/a> covers the newer orexin-receptor antagonists, which are an increasingly common alternative to both doxepin and trazodone.<\/p>\n Both drugs are generic and inexpensive. Generic doxepin capsules and the brand Silenor (3 mg and 6 mg tablets) differ in price quite a bit, with Silenor running noticeably higher. Generic trazodone is one of the cheaper psychotropic prescriptions on the market. You can compare current generic doxepin and trazodone pricing at edrugstore.com if cost is part of your decision.<\/p>\n For long-term sleep use, low-dose doxepin generally has the safer profile, particularly for adults over 65 and for anyone without coexisting depression. Trazodone remains a reasonable choice when depression or anxiety travels with the insomnia, but the fall risk, orthostatic effects, and serotonergic interactions need to be weighed. The honest answer in the doxepin vs trazodone debate is that the "safer" drug depends on your other diagnoses, your other medications, and your age. Ask your prescriber or pharmacist to look at your full medication list before you commit to either one for the long haul.<\/p>\n This article is for informational purposes only and is not medical advice. Always consult a licensed pharmacist or physician before starting, stopping, or changing any medication.<\/strong><\/p>\n Doxepin vs trazodone for sleep, compared on long-term safety, side effects, and who should use which. Talk to a pharmacist today.<\/p>\n","protected":false},"author":34,"featured_media":43858,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_autoblog_aioseo_focus_keyphrase":"doxepin vs trazodone","_autoblog_aioseo_title":"Doxepin vs Trazodone for Sleep: Long-Term Safety","_autoblog_aioseo_description":"Doxepin vs trazodone for sleep, compared on long-term safety, side effects, and who should use which. Talk to a pharmacist today.","footnotes":""},"categories":[1931],"tags":[],"class_list":["post-43859","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-energy-sleep"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\tSide Effect Profiles That Matter Long-Term<\/h2>\n
\n
\n
\n
Which Drug Causes Fewer Long-Term Problems<\/h2>\n
Special Populations Where This Matters<\/h2>\n
Cost and Access<\/h2>\n
The Bottom Line on Doxepin vs Trazodone<\/h2>\n
References<\/h2>\n
\n